Find policies, billing codes, payers, states, and providers
CPT 87899: Immunoassay with Direct Optical Observation for Infectious Agents
CPT code 87899 is an unlisted laboratory CPT code used for the technical performance of an immunoassay with direct optical (visual) observation to detect infectious agents that do not have a specific existing test code. Nationally, this code is important for capturing reimbursement and utilization for uncommon or novel infectious-organism immunoassays performed in clinical and hospital laboratories. It serves as a catch-all when standardized CPT codes for particular pathogens are not available.
Key payers in the scope of commonly applied coverage policies include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on the clinical use of direct optical immunoassays, typical sites of service, and how 87899 is applied when specific analyte codes are absent. The publication summarizes how payers approach unlisted laboratory codes, highlights benchmark considerations for technical-component laboratory services, and outlines policy and billing elements that affect claim adjudication for novel or uncommon infectious-agent testing. The content provides practical clarity on coding intent, expected laboratory workflows, and the national relevance of using an unlisted CPT code for immunoassays until a specific CPT code is established.
Customize your policy alerts
Sign up for cpt 87899 policy alerts
Get alerted when payer policies referencing 87899 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 87899 describes a laboratory technical service that uses an immunoassay with direct optical (visual) observation to detect the presence of an infectious agent when no specific analysis code exists for that organism. The code covers the technical component of performing the laboratory procedure and reporting a direct visual immunoassay result.
Service type: Laboratory — immunoassay (direct optical/visual)
Typical site of service: Clinical laboratory or hospital laboratory setting, including independent diagnostic laboratories and hospital-based labs that perform immunoassay testing with direct optical readouts.